The Minnesota Prescription Monitoring Program (PMP) was established to promote public health and safety by detecting diversion and misuse of prescriptions for controlled substances as defined in Minnesota Statutes Section 152.126. Pharmacies and prescribers who dispense Schedule II-V substances submit prescription data into the PMP.Where can I find information about the PMP in Minnesota?
For additional information regarding the PMP, refer to Minnesota Statutes 152.126 Access the Prescription Monitoring Program. PMP is administrated by the Minnesota Board of Pharmacy.When to report gabapentin to the MN PMP?
Dispensers (pharmacies) licensed by the MN Board of Pharmacy must report daily, all Minnesota schedule II-V controlled substances, butalbital and gabapentin prescriptions to the Minnesota Prescription Monitoring Program (MN PMP), when dispensed in or into the State.How to become a Minnesota PMP gateway licensee?
Please review the Minnesota PMP Gateway Welcome Kit for more information regarding details and processes. If your organization is interested in integrating your health IT system with the Minnesota PMP, submit your request by clicking the link below. Complete the PMP Gateway Licensee Questionnaire (sent after submitting the request form)